3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Rectal Neoplasms
2
Colonic Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
Azacitidine
26
venetoclax
20
Cyclophosphamide
17
fludarabine phosphate
14
Whole-Body Irradiation
13
Biopsy
13
fludarabine
12
Specimen Handling
12
Tacrolimus
11
Mycophenolic Acid
11
Decitabine
10
Stem Cell Transplantation
9
Peripheral Blood Stem Cell Transplantation
9
Injections
8
Cytarabine
8
Busulfan
8
decitabine and cedazuridine drug combination
7
Melphalan
7
X-Rays
5
Hematopoietic Stem Cell Transplantation
5
Cyclosporine
5
Sirolimus
4
ruxolitinib
3
olutasidenib
3
enasidenib
3
cedazuridine
3
Magnetic Resonance Spectroscopy
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
2C4 antibody
×
1 year
×
Clear all
No trials found.